One of the primary objectives of the AIDS Program is to support research activities which will provide information that can be used to improve the therapy of AIDS. The retrovirus HTLV-III/LAV has been identified as an essential factor in the etiology of the acquired immunodeficiency syndrome (AIDS). The findings of HTLV-III/LAV prompts research to develop and evaluate specific therapy against retroviruses and their maintenance enzyme systems. Nonhuman primates have been infected with HTLV-III/LAV although none of these animals have developed the cancers or opportunistic infections characteristic of AIDS. Therefore, no suitable endpoints exist to evaluate therapies in the infected primates. However, several naturally occurring retroviral diseases exist. The retroviruses that cause these diseases have many of the same enzyme systems as HTLV-III/LAV. Presumably understanding the activity of antivirals in animals will help plan clinical trials in humans infected with HTLV-III/LAV.

Project Start
1985-12-16
Project End
1991-06-30
Budget Start
1990-08-29
Budget End
1991-06-30
Support Year
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Other Domestic Higher Education
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Tuntland, T; Ravasco, R J; al-Habet, S et al. (1994) Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina. Pharm Res 11:312-7
Tsai, C C; Tsai, C C; Roodman, S T et al. (1990) Mesenchymoproliferative disorders (MPD) in simian AIDS associated with SRV-2 infection. J Med Primatol 19:189-202
Tsai, C C; Follis, K E; Snyder, K et al. (1990) Maternal transmission of type D simian retrovirus (SRV-2) in pigtailed macaques. J Med Primatol 19:203-16
Tsai, C C; Follis, K E; Yarnall, M et al. (1990) In vitro screening for antiretroviral agents against simian immunodeficiency virus (SIV). Antiviral Res 14:87-98
Tsai, C C; Tsai, C C; Sligh, J M et al. (1989) Monoclonal antibodies to type D retrovirus (SRV-2). J Med Primatol 18:175-83
Tsai, C C; Yarnall, M; Follis, K E et al. (1989) Antigen capture assay for detection of simian type D retroviruses in cell cultures and plasma samples. Lab Anim Sci 39:554-9
Tsai, C C; Follis, K E; Yarnall, M et al. (1989) Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2. Antimicrob Agents Chemother 33:1908-14
Tsai, C C; Follis, K E; Benveniste, R E (1988) Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro. AIDS Res Hum Retroviruses 4:359-68